Robot surgeons take on gallbladder cancer in global trial

NCT ID NCT06246448

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study compares robotic-assisted surgery to traditional open surgery for gallbladder cancer. About 94 patients will be randomly assigned to one of the two procedures. The main goal is to see which approach helps patients recover faster after surgery, measured by pain control, mobility, and ability to eat. Researchers will also look at hospital stay length, complications, and quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Robotic-assisted surgery

What this could lead to

If successful, robotic surgery could lead to faster recovery and shorter hospital stays for gallbladder cancer patients.

What could go wrong

This is a relatively small trial (94 participants) and results may not apply to all patients. Robotic surgery may not improve outcomes or could have higher costs.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GALL BLADDER CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

gallbladder cancer gallbladder neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Region Stockholm

    RECRUITING

    Stockholm, Sweden

    Contact Email: •••••@•••••